Skip to main content
PharmGen Science, Inc. logo

PharmGen Science, Inc. — Investor Relations & Filings

Ticker · 004720 ISIN · KR7004720009 KO Manufacturing
Open in API
Filings indexed 296 across all filing types
Latest filing 2023-03-29 Declaration of Voting R…
Country KR South Korea
Listing KO 004720

About PharmGen Science, Inc.

http://www.pharmgenscience.com/en/

PharmGen Science, Inc. is a pharmaceutical company engaged in the research, development, production, and sale of medicaments. The company's portfolio encompasses a range of prescription (ETC) and over-the-counter (OTC) drugs, including analgesics, antibiotics, and anti-inflammatory agents. A key strategic focus for the company is the discovery and development of novel drugs for gastrointestinal (GI) disorders. PharmGen Science aims to provide integrated pharmaceutical solutions by leveraging its diverse infrastructure and global network.

Recent filings

Filing Released Lang Actions
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is an official announcement of the results of a General Meeting of Shareholders (정기주주총회결과) for PharmGen Science. It details the outcomes of various agenda items, including the approval of financial statements, the election of directors and auditors, and the approval of remuneration limits. This falls directly under the category of Declaration of Voting Results & Voting Rights Announcements, as it reports the official outcomes of shareholder votes.
2023-03-29 Korean
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information Classification · 100% confidence The document is a formal regulatory filing submitted to the Financial Services Commission/Korea Exchange regarding the appointment, dismissal, or resignation of outside directors (사외이사의 선임ㆍ해임 또는 중도퇴임에 관한 신고). This type of disclosure specifically concerns changes in the composition of the board of directors and senior management, which falls under the 'Board/Management Information' category.
2023-03-29 Korean
감사보고서제출
Audit Report / Information Classification · 100% confidence The document is a regulatory filing titled 'Audit Report Submission' (감사보고서 제출) from PharmGen Science. It provides a summary of the audit opinion (unqualified/appropriate) and key financial data (assets, liabilities, profit/loss) for both consolidated and separate financial statements. While it contains financial data, it is a short regulatory announcement (under 5,000 characters) notifying the market that the audit report has been submitted to the regulator, rather than the full, multi-page audit report document itself. Therefore, it falls under the 'Report Publication Announcement' (RPA) category. FY 2022
2023-03-21 Korean
사업보고서 (2022.12)
Annual Report Classification · 100% confidence The document is titled '사업보고서' (Business Report) for the 57th fiscal year (2022), which is the standard Korean regulatory filing equivalent to an Annual Report (10-K). It contains comprehensive company information, history, capital structure, and management details, consistent with the requirements for an annual financial report. FY 2022
2023-03-21 Korean
[기재정정]주주총회소집결의
AGM Information Classification · 100% confidence The document is a formal 'Notice of Convocation of General Meeting of Shareholders' (주주총회소집결의) and a subsequent amendment (정정신고) for PharmGen Science. It details the agenda for the upcoming Annual General Meeting (AGM), including the election of directors, auditors, and approval of financial statements. Since it pertains to the organization and agenda of an AGM, it is classified as AGM-R.
2023-03-21 Korean
[기재정정]주주총회소집공고
AGM Information Classification · 98% confidence The document is a 'Notice of Convocation of General Meeting of Shareholders' (주주총회소집공고) which includes detailed financial statements (balance sheets, income statements, cash flow statements) for the fiscal year 2022. While it contains financial data, it is primarily a proxy-related document for an upcoming shareholder meeting, specifically detailing the agenda items (including the approval of financial statements). In the context of the provided categories, this fits best as a Proxy Solicitation & Information Statement (PSI) as it provides the necessary information for shareholders to vote on the agenda items at the AGM.
2023-03-21 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.